Negative Symptoms of Schizophrenia Clinical Trial
Official title:
A Phase 3 Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Low- and High-dose Range Groups of SPD489 as Adjunctive Treatment to Established Maintenance Doses of Antipsychotic Medications on Negative Symptoms in Clinically Stable Adults Who Have Persistent Predominant Negative Symptoms of Schizophrenia
To assess the safety and efficacy of SPD489 low-dose and high-dose treatment groups to placebo when given as adjunctive therapy to antipsychotic medication in clinically stable adults with persistent predominant negative symptoms of schizophrenia.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05985993 -
Precise Intervention Technology and Application of Low Intensity TUS on Negative Symptoms of Schizophrenia
|
N/A | |
Not yet recruiting |
NCT06388551 -
A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017
|
Phase 1 | |
Completed |
NCT03397134 -
Study to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of Schizophrenia
|
Phase 3 | |
Recruiting |
NCT04620460 -
Efficacy and Mechanisms of Low-intensity Focused Ultrasound on Negative Symptoms in Patients With Schizophrenia
|
N/A |